Effects of the Combination of L-Arabinose and Indigestible Dextrin on Obesity
Not Applicable
Completed
- Conditions
- Obesity
- Registration Number
- NCT00880646
- Lead Sponsor
- Hiroshima University
- Brief Summary
This study aims to investigate the effect of supplement containing L-arabinose and indigestible dextrin on body mass index, body fat mass, abdominal circumference, visceral fat mass, and serum biochemical parameters in overweight subjects.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
- Healthy as based on medical history and physical examination
- BMI between 25 and 30 kg/m2
- Willing not to serve as blood donor during the study
- Informed consent signed
Exclusion Criteria
- Female subjects who are pregnant or nursing a child
- Participation in any clinical trial up to 90 days before Day 01 of this study
- Renal or hepatic dysfunction
- Heart disease
- Under medication
- Subjects who are taking functional food designed for weight loss or serum lipid reduction
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Body mass index 20 weeks
- Secondary Outcome Measures
Name Time Method Body fat mass Every 4 weeks (Overall 20 weeks) Serum adiponectin and leptin levels Week 0, Week 12 Abdominal circumference Every 4 weeks (Overall 20 weeks) Visceral fat area by CT scan Week 0, Week 12 Serum lipid profile Every 4 weeks (Overall 20 weeks) Fasting serum glucose and HbA1c levels Every 4 weeks (Overall 20 weeks) Frequency of bowel movement 20 weeks
Trial Locations
- Locations (1)
Hiroshima University
🇯🇵Hiroshima, Japan
Hiroshima University🇯🇵Hiroshima, Japan